Author:
Huang W.,Qu Z.-Q.,Li X.-D.,He P.,Ding N.,Zhang S.-L.,Wu M.C.
Subject
Pharmacology (medical),Pharmacology
Reference19 articles.
1. In vivo function tests of hepatic drug-oxidizing capacity in patients with liver disease;Tanaka;Journal of Clinical Pharmacy and Therapeutics,1997
2. CYP1A2 phenotype and genotype in a population from the Carboniferous Region of Coahuila, Mexico;Castorena-Torres;Toxicology Letters,2005
3. Cytochrome P-450-dependent hydroxylation and activity of glutathione-dependent liver enzymes in chronic liver diseases;Matiushin;Voprosy Meditsinskoi Khimii,1997
4. CYP2A13 metabolizes the substrates of human CYP1A2, phenacetin, and theophylline;Fukami;Drug Metabolism and Disposition,2007
5. Mechanisms of activation of phenacetin to reactive metabolites by cytochrome P-450: a theoretical study involving radical intermediates;Koymans;Molecular Pharmacology,1990
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献